40 related articles for article (PubMed ID: 1341052)
1. Multimeric structures influence the binding activity of bHLH muscle regulatory factors.
Wright WE; Catala F; Farmer K
Symp Soc Exp Biol; 1992; 46():79-87. PubMed ID: 1341052
[TBL] [Abstract][Full Text] [Related]
2. Alternative multimeric structures affect myogenin DNA binding activity.
Farmer K; Catala F; Wright WE
J Biol Chem; 1992 Mar; 267(8):5631-6. PubMed ID: 1312093
[TBL] [Abstract][Full Text] [Related]
3. Activation of muscle-specific transcription by myogenic helix-loop-helix proteins.
Olson E
Symp Soc Exp Biol; 1992; 46():331-41. PubMed ID: 1341046
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the myogenic determination factor myogenin with E12 and a DNA target: mechanism and kinetics.
Spinner DS; Liu S; Wang SW; Schmidt J
J Mol Biol; 2002 Mar; 317(3):431-45. PubMed ID: 11922675
[TBL] [Abstract][Full Text] [Related]
5. MyoD-E12 heterodimers and MyoD-MyoD homodimers are equally stable.
Maleki SJ; Royer CA; Hurlburt BK
Biochemistry; 1997 Jun; 36(22):6762-7. PubMed ID: 9184158
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antimyogenin antibodies define epitopes outside the bHLH domain where binding interferes with protein-protein and protein-DNA interactions.
Wright WE; Dac-Korytko I; Farmer K
Dev Genet; 1996; 19(2):131-8. PubMed ID: 8900045
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the DNA-binding properties of MyoD, myogenin, and E12 by fluorescence anisotropy.
Maleki SJ; Royer CA; Hurlburt BK
Biochemistry; 2002 Sep; 41(35):10888-94. PubMed ID: 12196028
[TBL] [Abstract][Full Text] [Related]
8. MyoD and achaete-scute: 4-5 amino acids distinguishes myogenesis from neurogenesis.
Davis RL; Cheng PF; Lassar AB; Thayer M; Tapscott S; Weintraub H
Princess Takamatsu Symp; 1989; 20():267-78. PubMed ID: 2562185
[TBL] [Abstract][Full Text] [Related]
9. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
Valdez MR; Richardson JA; Klein WH; Olson EN
Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein.
Johanson M; Meents H; Ragge K; Buchberger A; Arnold HH; Sandmöller A
Biochem Biophys Res Commun; 1999 Nov; 265(1):222-32. PubMed ID: 10548518
[TBL] [Abstract][Full Text] [Related]
11. The basic helix-loop-helix domain of the E47 transcription factor requires other protein regions for full DNA binding activity.
Lu J; Sloan SR
Biochem Biophys Res Commun; 2002 Feb; 290(5):1521-8. PubMed ID: 11820794
[TBL] [Abstract][Full Text] [Related]
12. High-level expression and purification of MyoD, myogenin, and E12.
Maleki SJ; Hurlburt BK
Protein Expr Purif; 1997 Feb; 9(1):91-9. PubMed ID: 9116507
[TBL] [Abstract][Full Text] [Related]
13. Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis.
Rawls A; Morris JH; Rudnicki M; Braun T; Arnold HH; Klein WH; Olson EN
Dev Biol; 1995 Nov; 172(1):37-50. PubMed ID: 7589813
[TBL] [Abstract][Full Text] [Related]
14. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
Grasberger H; Ye H; Mashima H; Bell GI
Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
[TBL] [Abstract][Full Text] [Related]
15. Target gene selectivity of the myogenic basic helix-loop-helix transcription factor myogenin in embryonic muscle.
Davie JK; Cho JH; Meadows E; Flynn JM; Knapp JR; Klein WH
Dev Biol; 2007 Nov; 311(2):650-64. PubMed ID: 17904117
[TBL] [Abstract][Full Text] [Related]
16. Acquisition of myogenic specificity through replacement of one amino acid of MASH-1 and introduction of an additional alpha-helical turn.
Dezan C; Meierhans D; Künne AG; Allemann RK
Biol Chem; 1999 Jun; 380(6):705-10. PubMed ID: 10430036
[TBL] [Abstract][Full Text] [Related]
17. Identification of MRF4, myogenin, and E12 oligomer complexes by chemical cross-linking and two-dimensional gel electrophoresis.
Lin H; Konieczny SF
J Biol Chem; 1992 Mar; 267(7):4773-80. PubMed ID: 1311321
[TBL] [Abstract][Full Text] [Related]
18. Preferential binding of MyoD-E12 versus myogenin-E12 to the murine sarcoma virus enhancer in vitro.
Czernik PJ; Peterson CA; Hurlburt BK
J Biol Chem; 1996 Apr; 271(15):9141-9. PubMed ID: 8621566
[TBL] [Abstract][Full Text] [Related]
19. Myogenin resides in the nucleus and acquires high affinity for a conserved enhancer element on heterodimerization.
Brennan TJ; Olson EN
Genes Dev; 1990 Apr; 4(4):582-95. PubMed ID: 2163343
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta represses the actions of myogenin through a mechanism independent of DNA binding.
Brennan TJ; Edmondson DG; Li L; Olson EN
Proc Natl Acad Sci U S A; 1991 May; 88(9):3822-6. PubMed ID: 1850837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
